Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 15, 2008 | VP, Medical Affairs | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 15,000 | -- | 38,638 | |
| Jul 14, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 1,543 | $12.61 | 1,966,851 | |
| Jul 14, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 57 | $12.61 | 73,446 | |
| Jul 11, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 8,573 | $12.55 | 1,968,394 | |
| Jul 11, 2008 | Director | Open market or private sale of non-derivative or derivative security | Form 4 | 320 | $12.55 | 73,503 | |
| Jul 07, 2008 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 100 | $10.69 | 39,233 | |
| Jul 07, 2008 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 200 | $10.75 | 39,033 | |
| Jul 07, 2008 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 92 | $11.19 | 38,941 | |
| Jul 07, 2008 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 300 | $11.22 | 38,641 | |
| Jul 07, 2008 | Director, President and CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 100 | $11.23 | 38,541 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.